Equities

Bionoid Pharma Inc

BINP:PKL

Bionoid Pharma Inc

Actions
  • Price (USD)0.10
  • Today's Change0.00 / 0.00%
  • Shares traded100.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 01 2024 15:46 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bionoid Pharma Inc., formerly Bronya International Corp., is a medical device company. The Company develops and markets medical devices and technologies for the orthopedic and pain management markets. The Company develops and commercializes a platform called muscle pattern recognition (MPR), a clinical tool for the analysis of muscle function in patients presenting with back pain. MPR provides information regarding muscle recruitment patterns in patients suffering from neck and back pain that can assist healthcare professionals in the evaluation and treatment of neck and back injuries and illnesses. The Company, through BIOflex Medical Magnetics, Inc., develops and sells magnetic therapy devices. The Company sells its products through several channels, including Web-based sales; corporate partnerships; direct response television (DRTV); retail distribution; Internet catalogs, and through a network of distributors across the world.

  • Revenue in USD (TTM)0.00
  • Net income in USD1.35m
  • Incorporated2006
  • Employees13.00
  • Location
    Bionoid Pharma Inc17011 Beach Blvd Ste 900HUNTINGTON BEACH 92647United StatesUSA
  • Phone+1 (714) 841-2670
  • Fax+1 (302) 645-1280
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hawkeye Systems Inc0.00-804.18k4.33m44.00---------0.1186-0.11860.00-0.290.00-------66.07-330.11-----------218.49---2.7810.45------4.85------
Arch Therapeutics Inc130.55k-8.43m4.40m8.00------33.70-3.68-3.680.0425-2.450.08330.0637--16,318.75-538.25-188.28---804.6333.37---6,458.14-26,945.920.0164-1.27----383.83---32.35---21.76--
Dror Ortho-Design Inc0.00-4.83m4.46m4.00--1.87-----0.0115-0.01150.000.00480.00-------357.10-140.50-595.21---------118,188.00----0.00-------1,896.02------
ADM Tronics Unlimited Inc2.85m-716.86k4.50m7.00--4.08--1.58-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Nu-Med Plus Inc0.00-119.16k4.69m2.00---------0.0014-0.00140.00-0.0020.00----0.00-350.01-447.69---------------22.74--------3.56------
ReShape Lifesciences Inc8.34m-10.92m4.84m31.00--1.07--0.5803-2.30-2.300.73190.19330.67810.81784.52268,871.00-88.83-136.06-162.20-194.3265.8556.30-130.99-408.361.26--0.00---22.79-0.947475.36---49.29--
Pressure Biosciences Inc1.98m-35.20m4.86m15.00------2.46-1.65-1.650.0885-0.92611.292.388.86131,850.70-1,916.46-872.30----40.4332.33-1,482.20-1,066.480.0136-0.595----14.37-4.25-97.72------
Encision Inc6.87m-448.00k4.99m31.00--2.25--0.7263-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
Sonendo Inc40.19m-57.74m5.38m216.00--0.2194--0.1339-0.6125-0.55520.4260.34820.44482.077.58186,055.60-63.91---78.82--27.64---143.67--2.14-10.830.4695--5.30---6.78------
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
BioSig Technologies Inc27.00k-25.25m5.79m4.00------214.34-3.24-3.240.0033-0.37760.008--1.746,750.00-728.65-269.73---363.1148.15---91,566.66-24,485.73---------93.71---6.52---9.58--
Telesis Bio Inc24.63m-47.13m6.05m137.00------0.2458-28.31-28.3114.8012.940.32313.275.58179,802.90-59.34---67.10--60.43---183.66--3.08-35.890.2015--0.2697---1.14------
ALR Technologies Inc9.49k-8.00m6.10m6.00------642.83-0.0147-0.01470.00002-0.04760.0358----1,581.67-3,015.28-12,861.64----62.49---84,283.24-406,011.30---0.8626---------42.72------
Caduceus Software Systems Corp0.00-117.60k6.21m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Aethlon Medical, Inc.574.25k-12.26m6.26m15.00--0.1537--10.90-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
Sigyn Therapeutics Inc0.00-3.56m6.43m5.00---------3.04-3.040.00-3.280.00----0.00-724.37-493.15-----------10,223.960.0199-1.92---------41.51------
Data as of Jul 01 2024. Currency figures normalised to Bionoid Pharma Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.